Dr. Dhinagaran M04 eLearning Consultation for Ministry of Health, Govt. of Thailand
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2019 - 2029
Project Lead
Dr. Dhinagaran
Authors
Dr. Dhinagaran, Dr. Ryan, Dr. Bharat
Project Status
ongoing
Project Type
ICMR extramural